Tout DSpace

Afficher la notice abrégée

Clinical profile of severe asthmatics receiving biological treatment: see behind the scenes

dc.creatorKotsiou O.S., Gourgoulianis K.I., Daniil Z.en
dc.date.accessioned2023-01-31T08:44:46Z
dc.date.available2023-01-31T08:44:46Z
dc.date.issued2021
dc.identifier10.1080/02770903.2020.1750629
dc.identifier.issn02770903
dc.identifier.urihttp://hdl.handle.net/11615/75210
dc.description.abstractThe clinical phenotyping of severe asthma could improve treatment outcomes, quality of life, morbidity, and mortality of asthma patients. The growing availability of rich clinical data could provide opportunities to address a broad range of real-world questions regarding clinical phenotyping and effective therapeutic approaches of severe asthma. Accordingly, in this Letter to the Editor, we provide data relevant to constructing the clinical profile of a Greek severe asthma patient cohort who receive biological treatment. © 2020 Taylor & Francis Group, LLC.en
dc.language.isoenen
dc.sourceJournal of Asthmaen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85083555472&doi=10.1080%2f02770903.2020.1750629&partnerID=40&md5=f17e2bd8d143adc7e7905a983b8ac411
dc.subjectbronchodilating agenten
dc.subjectmepolizumaben
dc.subjectomalizumaben
dc.subjectantiasthmatic agenten
dc.subjectmonoclonal antibodyen
dc.subjectomalizumaben
dc.subjectadulten
dc.subjectallergic rhinitisen
dc.subjectAsthma Control Testen
dc.subjectbiological therapyen
dc.subjectbronchiectasisen
dc.subjectclinical articleen
dc.subjectclinical featureen
dc.subjectcohort analysisen
dc.subjectcomorbidityen
dc.subjectcomparative studyen
dc.subjectcontrolled studyen
dc.subjectdemographyen
dc.subjectdisease controlen
dc.subjectdisease durationen
dc.subjecteosinophil counten
dc.subjecteosinophiliaen
dc.subjectevidence based practiceen
dc.subjectex-smokeren
dc.subjectfemaleen
dc.subjectforced expiratory volumeen
dc.subjectgastroesophageal refluxen
dc.subjectGreeceen
dc.subjecthumanen
dc.subjectLetteren
dc.subjectmaleen
dc.subjectmedical historyen
dc.subjectmiddle ageden
dc.subjectmorbidityen
dc.subjectmortalityen
dc.subjectnon-smokeren
dc.subjectobese patienten
dc.subjectobesityen
dc.subjectphenotypeen
dc.subjectquality of lifeen
dc.subjectretrospective studyen
dc.subjectsevere asthmaen
dc.subjecttotal quality managementen
dc.subjecttreatment outcomeen
dc.subjectasthmaen
dc.subjectAnti-Asthmatic Agentsen
dc.subjectAntibodies, Monoclonal, Humanizeden
dc.subjectAsthmaen
dc.subjectHumansen
dc.subjectOmalizumaben
dc.subjectQuality of Lifeen
dc.subjectTaylor and Francis Ltd.en
dc.titleClinical profile of severe asthmatics receiving biological treatment: see behind the scenesen
dc.typeotheren


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée